Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Proteogenomics
44%
Mutation
41%
ivosidenib
23%
Acute Promyelocytic Leukemia
20%
venetoclax
18%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16%
Fibroblast Growth Factor 2
16%
Imatinib Mesylate
16%
quizartinib
15%
Hematologic Neoplasms
15%
Organism Cloning
14%
Therapeutics
14%
Leukemia
14%
Proteomics
13%
Protein-Tyrosine Kinases
13%
Neoplasms
13%
gilteritinib
12%
Survival
11%
Precision Medicine
11%
AG-221
11%
Cytogenetics
11%
Receptor Protein-Tyrosine Kinases
11%
SB939 compound
11%
Pharmaceutical Preparations
11%
Attenuated Adenomatous Polyposis Coli
11%
CPX-351
10%
ponatinib
10%
Coenzyme A Ligases
10%
Genes
10%
long-chain-fatty-acid-CoA ligase
9%
Isocitrate Dehydrogenase
9%
Phosphotransferases
9%
Recurrence
9%
Growth
8%
Dasatinib
8%
Bone Marrow
8%
High-Throughput Nucleotide Sequencing
8%
Diacylglycerol Kinase
7%
Leukemia, Myelomonocytic, Chronic
7%
Myeloid Cells
7%
Diglycerides
7%
Apoptosis
7%
Calreticulin
7%
GATA2 Deficiency
7%
Myelodysplastic Syndromes
7%
Spliceosomes
7%
Stromal Cells
7%
trametinib
7%
Epigenomics
7%
Chemical Compounds
Mutation
23%
Ponatinib
10%
Imatinib
9%
Neurotrophic
8%
Tyrosine Kinase Inhibitor
8%
Acyl-CoA
8%
Resistance
7%
Cytogenetics
7%
Protein
7%
Growth Factor
6%
High Throughput Screening
5%
Drug
5%
Acetylation
5%
Oxidative Stress
5%
Chain Reaction
5%
Adenosine
5%